347 related articles for article (PubMed ID: 22418841)
1. [Methods to increase participation in cancer screening programmes].
Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
[TBL] [Abstract][Full Text] [Related]
2. [Cancer screening programme in health care workers].
Pisati G; Cerri S; Marinelli M; Tedeschi B; Valsecchi E
G Ital Med Lav Ergon; 2011; 33(2 Suppl):57-60. PubMed ID: 22187927
[TBL] [Abstract][Full Text] [Related]
3. Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.
Zapka J; Taplin SH; Price RA; Cranos C; Yabroff R
J Natl Cancer Inst Monogr; 2010; 2010(40):58-71. PubMed ID: 20386054
[TBL] [Abstract][Full Text] [Related]
4. Methods to increase participation in organised screening programs: a systematic review.
Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
[TBL] [Abstract][Full Text] [Related]
5. Are smokers less likely to seek preventive healthcare measures in Italy?
Carreras G; Iannucci L; Costa G; Chellini E; Gorini G
Eur J Cancer Prev; 2018 Sep; 27(5):507-513. PubMed ID: 28379886
[TBL] [Abstract][Full Text] [Related]
6. [Organized colorectal cancer screening].
Rouëssé J; Sancho-Garnier H;
Bull Acad Natl Med; 2014 Feb; 198(2):387-99. PubMed ID: 26263711
[TBL] [Abstract][Full Text] [Related]
7. What is the most cost-effective population-based cancer screening program for Chinese women?
Woo PP; Kim JJ; Leung GM
J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
[TBL] [Abstract][Full Text] [Related]
8. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
[TBL] [Abstract][Full Text] [Related]
9. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
[TBL] [Abstract][Full Text] [Related]
10. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
Gyrd-Hansen D
Crit Rev Oncol Hematol; 1999 Nov; 32(2):133-44. PubMed ID: 10612013
[No Abstract] [Full Text] [Related]
11. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
[TBL] [Abstract][Full Text] [Related]
12. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
[TBL] [Abstract][Full Text] [Related]
13. Organizational factors and the cancer screening process.
Anhang Price R; Zapka J; Edwards H; Taplin SH
J Natl Cancer Inst Monogr; 2010; 2010(40):38-57. PubMed ID: 20386053
[TBL] [Abstract][Full Text] [Related]
14. [The diffusion of screening programmes in Italy, year 2010].
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
[TBL] [Abstract][Full Text] [Related]
15. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
[TBL] [Abstract][Full Text] [Related]
16. [The state of the organized screening in Hungary in 2006].
Kovács A; Döbrôssy L; Budai A; Cornides A; Boncz I
Orv Hetil; 2007 Mar; 148(10):435-40. PubMed ID: 17350908
[TBL] [Abstract][Full Text] [Related]
17. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
18. Cancer screening before and after switching to a high-deductible health plan.
Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
[TBL] [Abstract][Full Text] [Related]
19. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
20. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
